Approval · Notice of Compliance 9303 · 2008
REVLIMID: Notice of Compliance 9303
Issued January 17, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 9303
- Date
- January 17, 2008
- Company
- Celgene IncSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic agent, immunomodulatory agent
- With conditions
- Yes (NOC/c)
Products in this notice
Medicinal ingredients
- LENALIDOMIDE 5 MG per CAP
- LENALIDOMIDE 10 MG per CAP